CircuLite®, Inc. today announced that it has received a grant from the Cardiovascular Medical Research and Education Fund, Inc. to fund the development of a right-heart circulatory support system based upon CircuLite’s Synergy® Micro-pump for the treatment of right heart failure due to pulmonary arterial hypertension and other causes.

This article was corrected Dec. 28, 2011. An explanation follows. Recovering from the failure of an oral supplement to treat pulmonary arterial hypertension, United Therapeutics has received approval in France for an intravenous treatment.

Recovering from the failure of an oral supplement to treat pulmonary arterial hypertension, United Therapeutics has received approval in France for an intravenous treatment.

Recovering from the failure of an oral supplement to treat pulmonary arterial hypertension, United Therapeutics has received approval in France for an intravenous treatment.

Intravenous Remodulin Approved For Pulmonary Arterial Hypertension Treatment